Результати пошуку - Nikolay Conev

  • Показ 1 - 7 результатів із 7
Уточнити результати
  1. 1
    Circulating Histones to Detect and Monitor the Progression of Cancer

    Circulating Histones to Detect and Monitor the Progression of Cancer за авторством Desislava K. Tsoneva, Martin Ivanov, Nikolay Conev, Rostislav Manev, Dragomir Stoyanov, Manlio Vinciguerra

    Опубліковано 2023
    Отримати повний текст Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  2. 2
    Serum expression levels of miR-17, miR-21, and miR-92 as potential biomarkers for recurrence after adjuvant chemotherapy in colon cancer patients

    Serum expression levels of miR-17, miR-21, and miR-92 as potential biomarkers for recurrence after adjuvant chemotherapy in colon cancer patients за авторством Nikolay Conev, Ivan Donev, Assia Konsoulova, Trifon Chervenkov, Yаvor Kashlov, Krasimir Ivanov

    Опубліковано 2015
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  3. 3
    Neutrophil to lymphocyte ratio as a potential predictive marker for treatment with pembrolizumab as a second line treatment in patients with non-small cell lung cancer

    Neutrophil to lymphocyte ratio as a potential predictive marker for treatment with pembrolizumab as a second line treatment in patients with non-small cell lung cancer за авторством Mila Petrova, Mariyana Eneva, Jeliazko Arabadjiev, Nikolay Conev, E Dimitrová, Krassimir Koynov, Teodora Karanikolova, Spartak Valev, Radostina Gencheva, Georgi Zhbantov, Anika Ivanova, Iva I. Sarbianova, Constanta Timcheva, Ivan Donev

    Опубліковано 2020
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  4. 4
    RIPK3 expression as a potential predictive and prognostic marker in metastatic colon cancer

    RIPK3 expression as a potential predictive and prognostic marker in metastatic colon cancer за авторством Nikolay Conev, E Dimitrová, Margarita K. Bogdanova, Yаvor Kashlov, Borislav Chaushev, Maria Radanova, Dilyan Petrov, Kaloyan Georgiev, Chavdar Bachvarov, G Todorov, Kalin Kalchev, Hristo Popov, Rostislav Manev, Ivan Donev

    Опубліковано 2019
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  5. 5
    Impact of Brain Metastases on Treatment Patterns and Outcomes With First-Line Durvalumab Plus Platinum-Etoposide in Extensive-Stage SCLC (CASPIAN): A Brief Report

    Impact of Brain Metastases on Treatment Patterns and Outcomes With First-Line Durvalumab Plus Platinum-Etoposide in Extensive-Stage SCLC (CASPIAN): A Brief Report за авторством Yuanbin Chen, Luis Paz‐Ares, Niels Reinmuth, Marina Chiara Garassino, Galina Statsenko, Maximilian J. Hochmair, Mustafa Özgüroğlu, Francesco Verderame, Libor Havel, György Losonczy, Nikolay Conev, Katsuyuki Hotta, Jun Ho Ji, Stuart Spencer, Tapashi Dalvi, Haiyi Jiang, Jonathan W. Goldman

    Опубліковано 2022
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  6. 6
    Durvalumab, with or without tremelimumab, plus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer: 3-year overall survival update from CASPIAN

    Durvalumab, with or without tremelimumab, plus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer: 3-year overall survival update from CASPIAN за авторством Luis Paz‐Ares, Y Chen, Niels Reinmuth, Katsuyuki Hotta, Dmytro Trukhin, Galina Statsenko, Maximilian J. Hochmair, Mustafa Özgüroğlu, Jun Ho Ji, Marina Chiara Garassino, Олександр Войтко, Artem Poltoratskiy, E. Musso, Libor Havel, Igor Bondarenko, György Losonczy, Nikolay Conev, Helen Mann, Tapashi Dalvi, Haiyi Jiang, Jonathan W. Goldman

    Опубліковано 2022
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  7. 7
    Durvalumab ± Tremelimumab + Platinum-Etoposide in Extensive-Stage Small Cell Lung Cancer (CASPIAN): Outcomes by PD-L1 Expression and Tissue Tumor Mutational Burden

    Durvalumab ± Tremelimumab + Platinum-Etoposide in Extensive-Stage Small Cell Lung Cancer (CASPIAN): Outcomes by PD-L1 Expression and Tissue Tumor Mutational Burden за авторством Luis Paz‐Ares, Marina Chiara Garassino, Yuanbin Chen, Niels Reinmuth, Katsuyuki Hotta, Artem Poltoratskiy, Dmytro Trukhin, Maximilian J. Hochmair, Mustafa Özgüroğlu, Jun Ho Ji, Galina Statsenko, Nikolay Conev, Igor Bondarenko, Libor Havel, György Losonczy, Mingchao Xie, Zhongwu Lai, Nadia Godin-Heymann, Helen Mann, Haiyi Jiang, Yashaswi Shrestha, Jonathan W. Goldman

    Опубліковано 2023
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:

Інструменти для пошуку: